Prudential Financial’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.42M | Sell |
26,151
-1,160
| -4% | -$196K | 0.01% | 980 |
|
2025
Q1 | $4.92M | Sell |
27,311
-13,882
| -34% | -$2.5M | 0.01% | 848 |
|
2024
Q4 | $6.82M | Buy |
41,193
+3,254
| +9% | +$538K | 0.01% | 754 |
|
2024
Q3 | $6.91M | Sell |
37,939
-8,599
| -18% | -$1.57M | 0.01% | 837 |
|
2024
Q2 | $8.55M | Buy |
46,538
+8,693
| +23% | +$1.6M | 0.01% | 706 |
|
2024
Q1 | $6.73M | Sell |
37,845
-1,711
| -4% | -$304K | 0.01% | 814 |
|
2023
Q4 | $4.91M | Sell |
39,556
-30
| -0.1% | -$3.72K | 0.01% | 942 |
|
2023
Q3 | $4.66M | Buy |
39,586
+29,895
| +308% | +$3.52M | 0.01% | 920 |
|
2023
Q2 | $1.14M | Buy |
+9,691
| New | +$1.14M | ﹤0.01% | 1747 |
|
2023
Q1 | – | Sell |
-5,096
| Closed | -$404K | – | 2638 |
|
2022
Q4 | $404K | Sell |
5,096
-2,795
| -35% | -$221K | ﹤0.01% | 2120 |
|
2022
Q3 | $550K | Sell |
7,891
-3,050
| -28% | -$213K | ﹤0.01% | 2032 |
|
2022
Q2 | $718K | Sell |
10,941
-9,950
| -48% | -$653K | ﹤0.01% | 1952 |
|
2022
Q1 | $1.39M | Buy |
+20,891
| New | +$1.39M | ﹤0.01% | 1717 |
|